KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Operating Expenses (2017 - 2026)

Cardlytics filings provide 10 years of Operating Expenses readings, the most recent being $42.6 million for Q1 2026.

  • Quarterly Operating Expenses fell 36.95% to $42.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $301.7 million through Mar 2026, down 33.09% year-over-year, with the annual reading at $335.1 million for FY2025, 29.28% down from the prior year.
  • Operating Expenses hit $42.6 million in Q1 2026 for Cardlytics, down from $62.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $465.1 million in Q4 2022 and bottomed at $32.3 million in Q1 2022.
  • Average Operating Expenses over 5 years is $120.2 million, with a median of $85.4 million recorded in 2024.
  • The largest annual shift saw Operating Expenses surged 336.92% in 2022 before it tumbled 58.7% in 2023.
  • Cardlytics' Operating Expenses stood at $465.1 million in 2022, then tumbled by 58.7% to $192.1 million in 2023, then crashed by 57.15% to $82.3 million in 2024, then fell by 24.45% to $62.2 million in 2025, then plummeted by 31.51% to $42.6 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Operating Expenses are $42.6 million (Q1 2026), $62.2 million (Q4 2025), and $120.9 million (Q3 2025).